Net profit of Syngene International declined 8.93% to Rs 106.10 crore in the quarter ended September 2024 as against Rs 116.50 crore during the previous quarter ended September 2023. Sales declined 2.10% to Rs 891.00 crore in the quarter ended September 2024 as against Rs 910.10 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales891.00910.10 -2 OPM %27.4727.92 - PBDT248.20262.70 -6 PBT137.30158.10 -13 NP106.10116.50 -9 Powered by Capital Market - Live News

The Board of Syngene International at its meeting held on 23 October 2024 has approved the following change in management:Resignation of Sibaji Biswas, Executive Director and Chief Financial Officer (Key Managerial Personnel) from the services of the Company with effect from 30 November 2024. Appointment of Deepak Jain as the Chief Financial Officer and a Key Managerial Personnel of the Company effective from 01 December 2024. Appointment of Dr. Jayashree Aiyar as Chief Scientific Officer and a member of the Executive Committee (Senior Management Personnel) of the Company effective from 23 October 2024.Powered by Capital Market - Live News

Syngene International will hold a meeting of the Board of Directors of the Company on 23 October 2024Powered by Capital Market - Live News

Net profit of Syngene International declined 18.95% to Rs 75.70 crore in the quarter ended June 2024 as against Rs 93.40 crore during the previous quarter ended June 2023. Sales declined 2.28% to Rs 789.70 crore in the quarter ended June 2024 as against Rs 808.10 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales789.70808.10 -2 OPM %21.5026.22 - PBDT176.20225.00 -22 PBT69.30122.90 -44 NP75.7093.40 -19 Powered by Capital Market - Live News

Syngene International announced that the 31th Annual General Meeting (AGM) of the company will be held on 24 July 2024.Powered by Capital Market - Live News